Inflation-adjusted annual cost of U.S. medical school attendance increased from $51,400 to $71,000 between 2008 and 2020
MONDAY, Dec. 8, 2025 (HealthDay News) — From 2008 to 2020, the cost of U.S. medical school attendance increased, with trainees increasingly relying on federal loans, according to a research letter published online Nov. 26 in the Journal of the American Medical Association.
Tarun Ramesh, M.D., from Massachusetts General Hospital in Boston, and colleagues examined trends in federal loan use among medical students and those most affected by the 2025 One Big Beautiful Bill Act, which eliminated Graduate PLUS Loans, by analyzing 2008 to 2020 National Postsecondary Student Aid Study data. The sample included medical students (weighted, 383,754 students) across all years of medical school. The primary outcomes were having any Graduate PLUS Loans, having annual federal loans of more than $50,000 in the survey year, and having cumulative undergraduate and graduate federal loans of more than $200,000.
The researchers found that the inflation-adjusted annual cost of medical school attendance increased from $51,400 to $71,000 between 2008 and 2020. The proportion of students using Graduate PLUS Loans increased from 13 percent in 2008 to 47 percent in 2020, while annual federal loans exceeded $50,000 for 7.7 and 40 percent, respectively; and lifetime federal loans exceeded $200,000 for 0.6 and 14 percent, respectively. Over the course of medical school, the proportion of students with lifetime federal loans exceeding $200,000 increased.
“The average cost of attending medical school has greatly increased in just over a decade,” Ramesh said in a statement. “Federal loan restrictions could leave many medical students, especially those from low-income backgrounds, without affordable options to complete their training.”
Abstract/Full Text (subscription or payment may be required)
Reduction Seen in Services Following Launch of Prior Authorization Pilot Program
Hospital Outcomes Better When Patients Treated by Female Physicians
More Than 1 in 4 Americans Misrepresent Symptoms to Get Antibiotics
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Mivocabtagene Autoleucel Shows Promise in Stiff Person Syndrome
Personality Measures Provide Clinically Meaningful Insight Into bvFTD
Mental Health Diagnoses Rise With Medical Complexity, Chronicity in Children
CDC: 1 in 10 U.S. Adults Reported GLP-1 Medication Use July to August 2025